Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
JAMA|January 5, 2002
Quinolones and false-positive urine screening for opiates by immunoassay technologyL R Baden, G Horowitz, H Jacoby, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolatesG M Eliopoulos, A Gardella, P DeGirolami, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1987
In vitro activity of BMY-28100, a new oral cephalosporinG M Eliopoulos, E Reiszner, C Wennersten, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agentsY Carmeli, N Troillet, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1985
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticG M Eliopoulos, C Thauvin, B Gerson, et al.
The Medical Journal of Australia|March 6, 1995
Home intravenous antibiotic therapy. A safe and effective alternative to inpatient careM L Grayson, J Silvers, J Turnidge
The Medical Journal of Australia|February 20, 1989
Gastroenteritis associated with Campylobacter cinaediM L Grayson, W Tee, B Dwyer
Antimicrobial Agents and Chemotherapy|March 1, 1993
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureusA Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1989
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolatesG M Eliopoulos, K Klimm, M J Ferraro, et al.
Pageof 18